ResMed Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ResMed Inc. with three other
companies in this sector in the United States:
Cantel Medical Corp.
sales of $664.76 million
of which 51%
was Endoscope Reprocessing Products),
of which 100%
was Automated Blood), and
Hill-Rom Holdings, Incorporation
of which 41%
was North America).
ResMed Inc. reported sales of $1.84 billion
June of 2016.
increase of 9.5%
versus 2015, when the company's sales were $1.68 billion.
Sales at ResMed Inc. have increased during each of the previous five years
(and since 2011, sales have increased a total of 48%).